Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinoma
Figure 8.Clinical subgroup analysis of the risk model. Gender (A, B). Tumor grading (C, D). Tumor staging (E, F).